Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmaceutical statistics

Showing results (11-20 of 1,234) with videos related to

Pageof 124
Sort By:
Pharmaceutical Statistics|July 12, 2022
Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessmentsChristopher J Weir, Rod S Taylor
Pharmaceutical Statistics|October 7, 2010
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studiesPeter C Austin
Pharmaceutical Statistics|October 23, 2010
Review of the statistical analysis of the dog telemetry studyMike Aylott, Simon Bate, Susie Collins, et al.
Pharmaceutical Statistics|August 26, 2010
Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspectiveYuki Ando, Toshimitsu Hamasaki
Pharmaceutical Statistics|February 11, 2011
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'Timothy H Montague, Diane Potvin, Charles E Diliberti, et al.
Pharmaceutical Statistics|January 27, 2011
A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studiesCarmen Navarro-Fontestad, Isabel González-Álvarez, Carlos Fernández-Teruel, et al.
Pharmaceutical Statistics|June 23, 2010
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials--Asian perspectiveHsiao-Hui Tsou, Shein-Chung Chow, K K Gordon Lan, et al.
Pharmaceutical Statistics|January 29, 2011
Making available information from studies sponsored by the pharmaceutical industry: some current practicesMichael O'Kelly, Steven A Julious, Stephen Pyke, et al.
Pharmaceutical Statistics|January 29, 2011
CommentarySteven Snapinn
Pharmaceutical Statistics|March 24, 2021
A simulation-free group sequential design with max-combo tests in the presence of non-proportional hazardsLili Wang, Xiaodong Luo, Cheng Zheng
Pageof 124

Showing results (11-20 of 1,234) with videos related to

Sort By:
Pageof 124
Pharmaceutical Statistics|July 12, 2022
Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessmentsChristopher J Weir, Rod S Taylor
Pharmaceutical Statistics|October 7, 2010
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studiesPeter C Austin
Pharmaceutical Statistics|October 23, 2010
Review of the statistical analysis of the dog telemetry studyMike Aylott, Simon Bate, Susie Collins, et al.
Pharmaceutical Statistics|August 26, 2010
Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspectiveYuki Ando, Toshimitsu Hamasaki
Pharmaceutical Statistics|February 11, 2011
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'Timothy H Montague, Diane Potvin, Charles E Diliberti, et al.
Pharmaceutical Statistics|January 27, 2011
A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studiesCarmen Navarro-Fontestad, Isabel González-Álvarez, Carlos Fernández-Teruel, et al.
Pharmaceutical Statistics|June 23, 2010
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials--Asian perspectiveHsiao-Hui Tsou, Shein-Chung Chow, K K Gordon Lan, et al.
Pharmaceutical Statistics|January 29, 2011
Making available information from studies sponsored by the pharmaceutical industry: some current practicesMichael O'Kelly, Steven A Julious, Stephen Pyke, et al.
Pharmaceutical Statistics|January 29, 2011
CommentarySteven Snapinn
Pharmaceutical Statistics|March 24, 2021
A simulation-free group sequential design with max-combo tests in the presence of non-proportional hazardsLili Wang, Xiaodong Luo, Cheng Zheng
Pageof 124